Fundraising Fox
Illumicell
Techstars '23Boston, US · 20 employees on LinkedIn · 7 known investors
Find your way into Illumicell
Sign up to see every warm intro you have to Illumicell
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Illumicell team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Illumicell develops AI-driven tools for early diagnosis and clinical decision support in healthcare, with a focus on deploying solutions in hospital settings. The company combines advanced artificial intelligence with cloud infrastructure and high-performance computing to deliver clinically meaningful solutions for medical specialties.
Also known as illumicell AI · IllumiCell AI · illumicell.ai
Founders & leadership
Investors · 7
How we know: Draper Associates's portfolio page · Not right? Tell us
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Also in the syndicate · 4
Company profile
researched Sep 2026illumicell AI is a healthcare technology company developing a portable "lab scanner" combined with a real-time AI platform that analyzes cells and biomarkers in bodily fluids within minutes. Its initial product is a portable sperm analysis system aimed at male fertility care, which the company says delivers clinical-grade measurement of sperm count, motility and morphology and produces 13x more data than standard tests. Beyond fertility, the company markets applications in immune health — converting live immune cell behavior into activation readouts for immuno-oncology trials run by pharmaceutical companies — and in autoimmune disease, where it measures immune shifts intended to help clinicians monitor and predict flare-ups.
The company was founded in 2023 by Harvard-trained physician Dr. Michel Bielecki (co-founder and CEO), former McKinsey consultant Jeyla Sadikova (co-founder and Chief Science Officer), and aerospace/rocket engineer Loup Cordey. It is based out of the Harvard Pagliuca Life Lab in Cambridge, Massachusetts, with a Boston-area office in Allston, MA and a second office in Zurich, Switzerland. Company materials describe the platform as designed to expand to other bodily fluids such as urine and cerebrospinal fluid, extending real-time cellular diagnostics to additional healthcare fields.
Compiled by commissioned research from 10 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Related companies · 3
Companies working in the same space as Illumicell.
Timeline · 6
launches, deals, and filingsICON Capital Group, LLC announced the successful completion of a Regulation Crowdfunding (Reg CF) offering for IllumiCell AI, with ICON as broker-of-record and MedTech Syndicates leading the investor syndicate. Proceeds are earmarked for product development and commercialization.
A panel discussion on how illumicell AI works with Japanese investors and advisors on the future of diagnostics.
Company representatives spoke at LSI Asia '25 in Singapore, joining panel discussions on the future of maternal and fetal health and on clinicians as investors in medtech innovation.
The company installed its first U.S.-based LuceDx system at Harvard's Pagliuca Life Lab.
The company closed a $2M pre-seed round backed by healthcare operators, clinicians and early-stage funds including KOFA Healthcare, Harvard Phoenix Venture Fund, MedTech Syndicates and urologist-investor Dr. Jeremy Teoh, to advance its portable lab scanner and real-time AI diagnostics platform, support clinical trials and prepare an FDA submission.
$2M source ↗
illumicell AI took second prize in the Google Cloud Startup Competition at the inaugural HumanX 2025 conference in Las Vegas.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 10
primary sources listed
- Illumicellillumicell.ai · web
10 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Illumicell do?
- Swiss-American techmed startup building a portable cell scanner and real-time AI platform for fluid-based diagnostics, starting with semen analysis.
- Who founded Illumicell?
- Illumicell was founded by Javier, Jeyla Sadikova.
- Who are Illumicell's investors?
- Illumicell's investors include Draper Associates, Techstars, Canaan Partners.
- Where is Illumicell headquartered?
- Illumicell is headquartered in Boston, US.